Ladenburg Thalmann Financial Services’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $104K | Buy |
9,327
+3,000
| +47% | +$33.5K | ﹤0.01% | 2984 |
|
2019
Q3 | $36K | Sell |
6,327
-1,700
| -21% | -$9.67K | ﹤0.01% | 3664 |
|
2019
Q2 | $69K | Buy |
8,027
+1,100
| +16% | +$9.46K | ﹤0.01% | 3239 |
|
2019
Q1 | $56K | Buy |
6,927
+2,200
| +47% | +$17.8K | ﹤0.01% | 3335 |
|
2018
Q4 | $19K | Sell |
4,727
-1,000
| -17% | -$4.02K | ﹤0.01% | 3906 |
|
2018
Q3 | $32K | Hold |
5,727
| – | – | ﹤0.01% | 3615 |
|
2018
Q2 | $81K | Hold |
5,727
| – | – | ﹤0.01% | 2893 |
|
2018
Q1 | $81K | Hold |
5,727
| – | – | ﹤0.01% | 2893 |
|
2017
Q4 | $47K | Hold |
5,727
| – | – | ﹤0.01% | 3261 |
|
2017
Q3 | $68K | Buy |
5,727
+1,000
| +21% | +$11.9K | ﹤0.01% | 2871 |
|
2017
Q2 | $48K | Buy |
4,727
+2,600
| +122% | +$26.4K | ﹤0.01% | 3058 |
|
2017
Q1 | $25K | Sell |
2,127
-412
| -16% | -$4.84K | ﹤0.01% | 3414 |
|
2016
Q4 | $16K | Hold |
2,539
| – | – | ﹤0.01% | 3619 |
|
2016
Q3 | $20K | Hold |
2,539
| – | – | ﹤0.01% | 3414 |
|
2016
Q2 | $16K | Buy |
2,539
+1,412
| +125% | +$8.9K | ﹤0.01% | 3492 |
|
2016
Q1 | $10K | Hold |
1,127
| – | – | ﹤0.01% | 3714 |
|
2015
Q4 | $13K | Hold |
1,127
| – | – | ﹤0.01% | 3528 |
|
2015
Q3 | $11K | Hold |
1,127
| – | – | ﹤0.01% | 3480 |
|
2015
Q2 | $19K | Sell |
1,127
-2,150
| -66% | -$36.2K | ﹤0.01% | 3278 |
|
2015
Q1 | $51K | Buy |
3,277
+1,150
| +54% | +$17.9K | ﹤0.01% | 2543 |
|
2014
Q4 | $34K | Buy |
2,127
+400
| +23% | +$6.39K | ﹤0.01% | 2613 |
|
2014
Q3 | $18K | Sell |
1,727
-1,070
| -38% | -$11.2K | ﹤0.01% | 2754 |
|
2014
Q2 | $26K | Hold |
2,797
| – | – | ﹤0.01% | 2468 |
|
2014
Q1 | $19K | Buy |
2,797
+1,247
| +80% | +$8.47K | ﹤0.01% | 2617 |
|
2013
Q4 | $6K | Buy |
+1,550
| New | +$6K | ﹤0.01% | 3184 |
|